Wearable Injectors Market Expected to Grow at 9% CAGR from 2023 to 2035, Fueled by Technological Advancements and Improved Medication Adherence
Wednesday, September 6, 2023
DUBLIN, Aug. 29, 2023 /PRNewswire/ -- The "Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
In a landscape marked by relentless medical innovations, the global wearable injectors market is projected to scale remarkable heights, reaching a substantial valuation of $4.3 billion by the end of 2023.
Bolstered by a steady compound annual growth rate (CAGR) of approximately 9% throughout the forecast period, this growth trajectory is fueled by the mounting prevalence of chronic ailments. Conditions such as diabetes, autoimmune disorders, cardiovascular diseases, and cancer are on the rise, prompting pharmaceutical stakeholders to harness innovative strategies to address these challenges head-on.
Current Treatment Landscape
Within the spectrum of contemporary treatment options, the spotlight falls on both oral and parenteral administration of medications. Notably, parenteral drug administration, predominantly through injections, has garnered significant traction. However, this approach is not devoid of challenges - the need for frequent dosing, the potential for dosing errors, and the risk of needlestick injuries collectively erode patient adherence and therapeutic effectiveness.
Advancements in Drug Delivery
The pharmaceutical domain stands witness to a paradigm shift, thanks to groundbreaking technological advancements. This evolution has given birth to novel drug delivery devices, exemplified by the likes of wearable injectors, autoinjectors, and pen injectors.
Among these, wearable injectors occupy a pivotal position, boasting a category that encompasses on-body injectors and patch pumps. These devices wield the power of conferring sustained therapeutic effects, optimizing patient adherence and treatment outcomes. The availability of high-capacity wearable injectors streamlines the administration process and offers a plethora of dosing alternatives. Furthermore, these devices integrate cutting-edge safety mechanisms, effectively mitigating potential risks.
Key Market Insights
-- Elevated Convenience: The ascendancy of wearable injectors translates to
heightened patient convenience, leading to enhanced adherence and
improved health outcomes.
-- Diverse Applications: The utility of wearable injectors extends well
beyond diabetes management, embracing a multitude of chronic conditions.
-- Competitive Dynamics: The market landscape thrives on a dynamic
interplay between established industry titans and nimble startups.
-- Catalysts for Collaboration: On-body injectors and patch pumps are
pivotal drivers of collaborative endeavors within the market.
-- Expansion Strategies: Collaborations and acquisitions emerge as robust
drivers of market growth.
-- Diabetes: A Focal Point: Wearable infusion pumps emerge as indispensable
tools in diabetes management.
-- Firing up the Market Engine: The convergence of drug-device
combinations, the surge in chronic ailments, and substantial investor
funding collectively fuel market expansion.
-- Geographical Significance: North America is poised to exert its
dominance, sustaining its grip on the lion's share of the market.
Leading Manufacturers in the Wearable Injectors Market
Prominent players leaving an indelible mark on the wearable injectors market include:
-- CCBio
-- CeQur
-- Debiotech
-- Eli Lilly
-- Enable Injections
-- Gerresheimer
-- Insulet
-- Medtronic
-- Medtrum Technology
-- PharmaSens
-- Roche
-- SOOIL Development
-- Sonceboz
-- Weibel CDS
-- West Pharmaceuticals
Wearable Injectors Market Outlook
In a landscape where the demand for effective therapeutic solutions for chronic conditions is on the ascent, the wearable injectors market is poised for exponential growth. The pervasive adoption of wearable injectors across diverse medical domains, coupled with the continuous march of technological progress, forms the bedrock of market expansion. As the canvas of healthcare undergoes a transformative evolution, wearable injectors are primed to assume a pivotal role, driving patient care to new zeniths and ultimately shaping the contours of modern healthcare delivery.
Device Profiles
-- 3 mL Micropump (Furosemide)
-- 3M hMTS (Adalimumab)
-- D-mine Pump (Apomorphine)
-- FUROSCIX On-body Infusor (Furosemide)
-- Herceptin sc Injection (Herceptin)
-- ND0612H Belt Pump (Levodopa / Carbidopa)
-- ND0612L Belt Pump (Levodopa / Carbidopa)
-- ND0612L Next Generation Patch Pump (Levodopa / Carbidopa)
For more information about this report visit https://www.researchandmarkets.com/r/38myc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/wearable-injectors-market-expected-to-grow-at-9-cagr-from-2023-to-2035-fueled-by-technological-advancements-and-improved-medication-adherence-301912832.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
|
|
|
